Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
MRSNCompany Name
MERSANA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQMERSANA THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MRSN - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ -53.15M | $ -74.04M | 0% |
| 3/31/2025 | $ -30.87M | $ -74.01M | 0% |
| 12/31/2024 | $ -9.51M | $ -69.19M | 0% |
| 9/30/2024 | $ 1.05M | $ -74.62M | -7113.35% |
| 6/30/2024 | $ 8.43M | $ -104.77M | -1243.31% |
| 3/31/2024 | $ 27.98M | $ -134.81M | -481.73% |
| 12/31/2023 | $ 36.9M | $ -171.67M | -465.18% |
| 9/30/2023 | $ 52.2M | $ -197.05M | -377.53% |
| 6/30/2023 | $ 89.8M | $ -215.21M | -239.65% |
| 3/31/2023 | $ 64.29M | $ -213.12M | -331.47% |
Key Performance Insights, Last 5 Years
- MERSANA THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at -29.78%.
- Over the past 5 years, MERSANA THERAPEUTICS INC's average ROE has been -670.73%.
- The median ROE for MERSANA THERAPEUTICS INC during this period was -221.83%
- MERSANA THERAPEUTICS INC reached its highest ROE over the past 5 years at -29.78%.
- The lowest ROE recorded by MERSANA THERAPEUTICS INC in the same timeframe -7113.35%
MERSANA THERAPEUTICS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for MERSANA THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -75.45M ] / Equity [ $ 253.31M ]
(=) ROE [ -29.78% ] MRSN - Return on Equity, Last 5 years
-7113.35%
Minimum
Sep 30, 2024
-29.78%
Maximum
Sep 30, 2020
-670.73%
Average
-221.83%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |